Kidney Cancer Stages: Stage 1 Through Stage 4

Kidney cancer is divided into four stages based on the size of the tumor, whether it has spread to nearby tissues or lymph nodes, and whether it has reached distant organs. Stage 1 is the smallest and most contained, while Stage 4 means the cancer has spread beyond the kidney region. Each stage carries different survival odds and treatment paths, so understanding where a diagnosis falls on this scale matters for knowing what comes next.

How Kidney Cancer Is Staged

Staging relies on the TNM system, which evaluates three things: the size and extent of the primary tumor (T), whether nearby lymph nodes contain cancer cells (N), and whether the cancer has metastasized to distant parts of the body (M). Your medical team determines the stage primarily through imaging. A CT scan of the abdomen with contrast dye is the standard tool for evaluating both the tumor itself and whether it has spread locally. MRI is a reliable alternative, particularly for checking whether cancer has grown into major blood vessels near the kidney. A CT of the chest is also typically performed to check for lung involvement.

PET scans and bone scans are not part of routine staging for kidney cancer unless there are specific symptoms suggesting spread to those areas. Most people receive their stage after imaging is complete, sometimes with a biopsy to confirm the type of cancer cells involved.

Stage 1: Small Tumor, Confined to the Kidney

A Stage 1 kidney tumor is smaller than 7 centimeters at its widest point, roughly the size of an egg or smaller. It is entirely contained within the kidney, with no spread to lymph nodes or other organs. This is the most common stage at diagnosis because many kidney tumors are found incidentally during imaging for unrelated reasons.

Treatment for Stage 1 is usually surgery. For smaller tumors, surgeons can often remove just the tumor and a margin of healthy tissue while preserving the rest of the kidney. Larger Stage 1 tumors may require removal of the entire kidney. For very small, slow-growing tumors, particularly in older adults or people with other serious health conditions, doctors sometimes recommend active surveillance: monitoring the tumor with regular imaging rather than operating immediately.

Stage 2: Larger Tumor, Still Confined

Stage 2 means the tumor is larger than 7 centimeters but still has not grown outside the kidney. There is no lymph node involvement and no distant spread. The difference between Stage 1 and Stage 2 is purely about size.

Because these tumors are bigger, surgery typically involves removing the entire kidney along with some surrounding tissue. Even at this stage, the outlook is favorable since the cancer remains localized.

Stage 3: Spread to Nearby Structures

Stage 3 is where things become more complex. At this stage, the tumor can be any size, and one or more of the following has occurred: the cancer has grown into major blood vessels near the kidney (the renal vein or the large vein that carries blood back to the heart, called the vena cava), it has spread into the fatty tissue surrounding the kidney, it has reached the structures inside the kidney that collect urine, or it has spread to nearby lymph nodes.

A tumor can qualify as Stage 3 through vein involvement alone, lymph node involvement alone, or both. The key distinction from Stage 2 is that cancer is no longer fully contained within the kidney itself, but it has not yet traveled to distant organs.

Surgery remains the primary treatment, often involving removal of the entire kidney, the surrounding fat, and sometimes the affected portion of the vein. If lymph nodes are involved, those are removed as well. Some patients receive additional drug therapy after surgery to reduce the risk of recurrence. This is where immunotherapy or targeted therapy may enter the picture, using medications that either help your immune system recognize cancer cells or block the signals tumors use to grow new blood vessels.

Stage 4: Distant Spread

Stage 4 kidney cancer means one of two things: the tumor has grown through the outer fibrous shell surrounding the kidney (called Gerota’s fascia), possibly extending into the adrenal gland that sits on top of the kidney, or the cancer has spread to distant organs. The lungs and soft tissues are among the most common sites for kidney cancer metastases. Spread to the brain and bones can also occur.

Even at Stage 4, surgery sometimes plays a role. Removing the primary kidney tumor can improve outcomes in some cases, and patients with a single metastasis or a limited number of distant tumors can achieve prolonged survival when surgeons are able to remove both the kidney tumor and the metastatic sites. Drug therapies, including immunotherapy combinations and targeted therapies, are central to treatment at this stage and have improved outcomes significantly over the past two decades.

Survival Rates by Stage

The most widely used survival statistics come from the SEER database, which groups kidney cancer into three categories rather than four numbered stages. Based on people diagnosed between 2015 and 2021, the five-year relative survival rates are:

  • Localized (cancer confined to the kidney, covering Stages 1 and 2): 93%
  • Regional (spread to nearby structures or lymph nodes, roughly Stage 3): 76%
  • Distant (spread to faraway organs, Stage 4): 19%

Across all stages combined, the five-year survival rate is 79%. These numbers reflect averages across large populations. Individual outcomes vary based on the specific type of kidney cancer, the tumor’s grade, overall health, and how well the cancer responds to treatment. Survival rates also tend to improve over time as newer therapies become standard.

Staging vs. Grading

Staging and grading are two different measurements that appear on a pathology report, and they tell you different things. Staging describes how far the cancer has spread through the body. Grading describes how abnormal the cancer cells look under a microscope, which correlates with how aggressively the tumor is likely to behave.

Kidney cancer uses a four-tier grading system established by the World Health Organization and the International Society of Urological Pathology. Grade 1 cells look relatively normal and tend to grow slowly. Grade 4 cells appear highly abnormal and are associated with more aggressive behavior, including unusual cell shapes that signal rapid, disorganized growth. A Stage 1 tumor with a high grade may need closer monitoring or more aggressive treatment than a Stage 1 tumor with a low grade, so both numbers matter when your medical team is planning next steps.